Clinical Research

time-delayed MRI phases improve brain tumor visualization

Using multiple MRI phases after contrast injection significantly improves visualization of brain tumors

Researchers are proposing making additional phases beyond the 10-minute mark mandatory when analyzing brain metastases.

The EuroPCR 2024 meeting May 14-17 in Paris included four days of late-breaking interventional cardiology science presentations featured 12,100 participants, more than 550 educational sessions and 12 live cases. Photo courtesy of EuroPCR

5 takeaways from late-breaking studies at EuroPCR

The Society for Cardiovascular Angiography and Interventions offers its top five key takeaways from the EuroPCR 2024 meeting last week.

Thumbnail

Head CTs could present an opportunity to screen for osteoporosis

In individuals who have not completed a DEXA scan, head CT conducted for other reasons can offer insight into patients’ frontal bone density, a potential marker of osteoporosis.

Thumbnail

Biopsy before ablation has no cost advantage over both-at-once approach

Established guidelines recommend biopsying small tumors of the kidney ahead of any procedure to ablate them. A new study confirms the validity of pursuing another pathway.

depression and alcohol lead to impairment in functional connectivity of the brain

Combined, alcohol dependence and depression cause 'severe and extensive' brain connectivity impairment

Alcohol dependence and depression are known to affect the functional connectivity of the brain, but when the two co-occur, connectivity between certain regions is significantly worse, new MRI study shows.

Thumbnail

One adverse reaction to a GBCA significantly increases risk of another in the future

The type of gadolinium-based agent administered could also increase the risk of reaction, a new study suggests.

MDMA Ecstasy

FDA set to evaluate use of ‘ecstasy’ for treating PTSD

The party drug could soon be prescribed, in conjunction with psychological interventions, as a treatment for mental health disorders.

A newly identified PET imaging biomarker could help providers tailor immunotherapy treatments for patients with certain types of cancers.

Researchers identify new PET imaging biomarker capable of predicting immunotherapy success

A newly identified PET imaging biomarker could help providers tailor immunotherapy treatments for patients with certain types of cancers.